Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study

BACKGROUND: A new descriptive classification scheme for biomarkers used in Alzheimer's and cognitive aging research, labeled ATN, was recently proposed. One implementation of this ATN construct dichotomizes biomarkers of amyloid, tau, and neurodegeneration/neuronal injury as normal or abnormal...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Neurol
Hlavní autoři: Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Therneau, Terry M., Knopman, David S., Lowe, Val, Vemuri, Prashanthi, Mielke, Michelle M., Roberts, Rosebud O., Machulda, Mary M., Senjem, Matthew L., Gunter, Jeffrey L., Rocca, Walter A., Petersen, Ronald C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516534/
https://ncbi.nlm.nih.gov/pubmed/28456479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(17)30077-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky